Podiatrist, Foot & Ankle Surgery · El Paso, TX
NPI
1063609873
Since 2007
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7430 Remcon Cir, Bldg B -110
El Paso, TX, 79912
Phone (915) 544-2455
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
979 services
Medicare patients, 2024
153
Average age 74
Drug cost, 2024
$162K
810 prescriptions
Company payments, 2025
$608
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca J Rosado was code 99213 (office e&m - established), 342 times for 121 patients. In total Rebecca J Rosado billed 979 services in 32 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 342 | 121 | $61.57 | $21K |
| 11721 Nail Procedure | Office | 191 | 73 | $29.99 | $5,727 |
| 73630 X-ray - Lower Extremity | Office | 166 | 78 | $24.36 | $4,044 |
| 93922 Duplex Scan - Extremity Arteries | Office | 57 | 49 | $58.91 | $3,358 |
| 95923 Electrical Nerve Conductivity | Office | 56 | 48 | $84.31 | $4,721 |
| 99203 Office E&M - New | Office | 48 | 48 | $68.65 | $3,295 |
By year: 2022 $76K for 1,303 services; 2023 $64K for 1,202 services; 2024 $50K for 979 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca J Rosado prescribed most often to Medicare patients was Clobetasol Emollient (Clobetasol Propionate/Emoll), with 97 prescriptions and refills. In total Rebecca J Rosado wrote 810 Medicare prescriptions that cost $162K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Emollient Clobetasol Propionate/Emoll | 97 | 97 | 65 | $54K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 74 | 74 | 52 | $883 |
| Desonide Generic | 70 | 70 | 48 | $31K |
| Naproxen Generic | 66 | 70 | 51 | $498 |
| Mometasone Furoate Generic | 58 | 58 | 44 | $4,934 |
| Tramadol Hcl Generic | 51 | 51 | 36 | $248 |
| Clobetasol Propionate Generic | 44 | 45 | 31 | $10K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 41 | 41 | 27 | $545 |
| Gabapentin Generic | 26 | 28 | 12 | $118 |
| Promethazine Hcl Generic | 24 | 24 | 22 | $128 |
| Santyl Collagenase Clostridium Hist. | 19 | 21 | 15 | $13K |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 18 | 19 | 12 | $430 |
| Ibuprofen Generic | 16 | 17 | 12 | $234 |
| Terbinafine Hcl Generic | 16 | 16 | Under 11 | $156 |
| Prednisone Generic | 16 | 16 | 14 | $26.04 |
Brand drugs: 36 claims; generic drugs: 774 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca J Rosado $608 ($608 in general payments such as food, travel and fees) from 5 companies. The largest payer was Smith+Nephew, Inc. with $256.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.